
R&D / Formulation
Pharmaceutical formulation development support
Structuring an immediate-release tablet development so trial data leads to a scalable, documented formulation.
Illustrative use caseCapability
From prototype to a robust, scalable formulation: dosage-form design, optimisation and the process knowledge that makes a product manufacturable.


Formulation work succeeds when formulation, analytical and process decisions are made together. We structure development around critical quality attributes and use designed experiments to understand which variables matter before scale-up.
Dosage forms listed below are areas we can discuss and scope. Specific capability for any product category is confirmed only after technical assessment and partner availability.
Each activity shows who performs it. We do not claim facilities we do not own.
DGXP-led Led by the DGXPComplianceLab team Partner-coordinated Performed by a qualified partner, coordinated by us
Direct compression, wet and dry granulation, coating; hardness, friability and dissolution targets.
Powder and pellet filling, fill-weight uniformity and shell selection.
Solutions and suspensions: preservative efficacy, taste masking, viscosity and redispersibility.
Creams, gels and ointments: rheology, release testing and container compatibility.
Parenteral formulation considerations, filtration, terminal sterilisation versus aseptic route.
Modified release and enabling technologies, scoped case by case.
Reference product deformulation, Q1/Q2 assessment and comparative dissolution.
Root-cause analysis of variability and targeted reformulation.
Parameter studies, yield improvement and robustness evaluation.
Reduce variability in dissolution or content uniformity through a structured DoE.
Move from laboratory to pilot and exhibit scale with a documented rationale.
Stability-indicating methods ready for validation at the receiving laboratory.
A transfer package the manufacturing site can execute without re-discovery.
Illustrative use cases showing how this capability is typically applied.

R&D / Formulation
Structuring an immediate-release tablet development so trial data leads to a scalable, documented formulation.
Illustrative use case
Manufacturing / R&D
Reducing yield loss and in-process rejections in an oral solid dosage process.
Illustrative use case
CDMO / R&D
Coordinating formulation, analytical and scale-up work across a CDMO and a separate testing laboratory.
Illustrative use caseEvery engagement follows the same eight steps, scaled to the size and risk of the project.
Understand business and technical requirements.
Assess scientific, technical, regulatory and operational requirements.
Design the appropriate solution.
Identify appropriate internal and external capabilities and partners.
Coordinate and execute the project.
Test, verify, qualify or validate where applicable.
Create technical, quality and regulatory documentation.
Monitor, optimise and continuously improve.
Structured research and development support that moves a product idea through pre-formulation, formulation, analytical …
Identifying, evaluating and coordinating qualified external manufacturers so your product is made where the technical, …
Analytical testing, method work and stability programmes arranged with contract laboratories, with clear lines between …
We scope each request against partner capability. Oral solids are the most common starting point; other forms are assessed individually.
Yes. Development plans are built around critical quality attributes, risk assessment and designed experiments, in line with ICH Q8–Q10 principles.
Ownership and confidentiality are agreed in the project contract before work begins.
Share the product, stage and timeline. Capability is confirmed after technical assessment and partner availability.